搜索临床试验以:聚乙二醇干扰素 (Peginterferon) Alfa-2a
总计1251个结果
-
Tongji HospitalFujian Cosunter Pharmaceutical Co. Ltd; Beijing Kawin Technology Share-Holding Co., Ltd.完全的
-
Merck Sharp & Dohme LLC完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
Seoul National University HospitalHanyang University招聘中
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)完全的
-
Pontificia Universidad Catolica de ChileFONDECYT de iniciación 11201220招聘中
-
St. Luke's Medical Center完全的
-
National Institute of Allergy and Infectious Diseases...Schering-Plough完全的
-
Coordinación de Investigación en Salud, MexicoUniversity of Guadalajara; Instituto Mexicano del Seguro Social完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B完全的
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.完全的
-
USDA, Western Human Nutrition Research CenterInternational Centre for Diarrhoeal Disease Research, Bangladesh完全的
-
Bausch Health Americas, Inc.终止
-
University Hospital, BordeauxSchering-Plough完全的
-
Hepatitis Resource NetworkHoffmann-La Roche未知艾滋病毒感染 | Chronic Hepatitis C Infection in HIV Infected Persons美国
-
University of ManitobaRoche Pharma AG完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)未知
-
St. Luke's Medical Center未知
-
Chang Gung Memorial HospitalMerck Sharp & Dohme LLC未知
-
Universitair Ziekenhuis Brussel完全的
-
Saint Francis Memorial Hospital完全的
-
Pfizer完全的
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC终止
-
St. Vincent Medical Center - Los Angeles完全的
-
Benaroya Research InstituteSanofi完全的
-
Medical Research CouncilEuropean Organisation for Research and Treatment of Cancer - EORTC完全的
-
European Organisation for Research and Treatment...University of Glasgow完全的
-
Wiseman Research Initiatives LLC终止